Research Article
Bardoxolone Methyl Ameliorates Myocardial Ischemia/Reperfusion Injury by Activating the Nrf2/HO-1 Signaling Pathway
Figure 1
Bardoxolone methyl relieves myocardial I/R-induced cardiac impairment. (a) A scheme showing the timeline of surgical intervention and drug treatment in myocardial I/R rats. (b) Echocardiography was performed to examine the effects of BARD treatments on cardiac functions (). (c) Myocardial I/R injury serum markers (). and . ns: not significant.
(a) |
(b) |
(c) |